Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1986 1
1988 1
1990 1
1991 1
1996 1
1997 1
1998 1
2000 1
2001 2
2002 2
2004 1
2006 2
2008 3
2009 2
2010 1
2011 2
2012 1
2014 1
2017 1
2018 1
2019 2
2020 1
2021 2
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
PD-1 blockade and lenalidomide combination therapy for chronic active Epstein-Barr virus infection.
Song Y, Wang J, Wang Y, Wu L, You Y, Song D, Chen L, Meng G, He X, Cui T, Wang X, Yin Q, Wang Z. Song Y, et al. Clin Microbiol Infect. 2023 Jun;29(6):796.e7-796.e13. doi: 10.1016/j.cmi.2023.01.017. Epub 2023 Jan 24. Clin Microbiol Infect. 2023. PMID: 36702399 Free article.
OBJECTIVES: Chronic active Epstein-Barr virus infection (CAEBV) is a prototype of EBV-associated T-or NK-cell lymphoproliferative diseases. ...The significant therapeutic effect and the different characteristics between response and non-r …
OBJECTIVES: Chronic active Epstein-Barr virus infection (CAEBV) is a prototype of EBV-associated T …
Clinical Analysis of Chronic Active Epstein-Barr Virus Infection Involving the Gastrointestinal Tract.
Wei A, Li Z, Ma H, Zhang L, Zhang J, He L, Lian H, Zhang Q, Chen S, Xu J, Wang D, Liu W, Zhang R, Wang T. Wei A, et al. Pediatr Infect Dis J. 2023 Jan 1;42(1):13-19. doi: 10.1097/INF.0000000000003734. Epub 2022 Oct 11. Pediatr Infect Dis J. 2023. PMID: 36476520
BACKGROUND: Chronic active Epstein-Barr virus infection (CAEBV) is an intractable and progressive disease. ...The children's clinical manifestations, laboratory and ultrasound examinations, treatment and prognosis were observed. RE …
BACKGROUND: Chronic active Epstein-Barr virus infection (CAEBV) is an intractable and progressive …
Severe chronic active Epstein-Barr virus infection syndrome.
Okano M, Matsumoto S, Osato T, Sakiyama Y, Thiele GM, Purtilo DT. Okano M, et al. Clin Microbiol Rev. 1991 Jan;4(1):129-35. doi: 10.1128/CMR.4.1.129. Clin Microbiol Rev. 1991. PMID: 1848476 Free PMC article. Review.
Polyclonal gammopathy and bone marrow suppression are generally observed, and some patients develop B-cell or T-cell lymphoproliferation or lymphoma. ...
Polyclonal gammopathy and bone marrow suppression are generally observed, and some patients develop B-cell or T-cell lymphoproliferat …
Clinical Features and Prognostic Factors of Children with Chronic Active Epstein-Barr Virus Infection: A Retrospective Analysis of a Single Center.
Chen S, Wei A, Ma H, Zhang L, Lian H, Zhao Y, Zhang Q, Cheng F, Wang D, Wang T, Li Z, Zhang R. Chen S, et al. J Pediatr. 2021 Nov;238:268-274.e2. doi: 10.1016/j.jpeds.2021.07.009. Epub 2021 Jul 11. J Pediatr. 2021. PMID: 34260897
OBJECTIVE: To analyze the clinical characteristics, prognosis factors and risk factors of chronic active Epstein-Barr virus infection in children. STUDY DESIGN: Observational analysis of baseline data and follow-up evaluation data …
OBJECTIVE: To analyze the clinical characteristics, prognosis factors and risk factors of chronic active Epstein-Bar
Outcomes of programmed death protein-1 inhibitors treatment of chronic active Epstein Barr virus infection: A single center retrospective analysis.
Ma Y, Zhang P, Bao Y, Luo H, Wang J, Huang L, Zheng M. Ma Y, et al. Front Immunol. 2023 Mar 10;14:1093719. doi: 10.3389/fimmu.2023.1093719. eCollection 2023. Front Immunol. 2023. PMID: 36969150 Free PMC article.
For three CR patients, the median time and cycles from the first application of PD-1 inhibitor to clinical CR were 6 weeks (range, 4-10 weeks) and 3 cycles (range, 2-4 cycles), and molecular CR was achieved after a median of 16.7 weeks (range, 6.1-18.4 weeks) and 5 cycles (range, …
For three CR patients, the median time and cycles from the first application of PD-1 inhibitor to clinical CR were 6 weeks (range, 4-10 week …
Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection.
Liu A, Takakuwa T, Luo WJ, Fujita S, Aozasa K. Liu A, et al. Cancer Sci. 2006 Jul;97(7):605-10. doi: 10.1111/j.1349-7006.2006.00226.x. Cancer Sci. 2006. PMID: 16827800 Free PMC article.
Nasal natural killer (NK)/T-cell lymphoma (NKTCL) and chronic active Epstein-Barr virus infection (CAEBV) are relatively frequent, especially in Asia, and are poor in prognosis. ...ATR alterations were detected in two of eight NKTCL and i …
Nasal natural killer (NK)/T-cell lymphoma (NKTCL) and chronic active Epstein-Barr virus infection
Clinical analysis and follow-up study of chronic active Epstein-Barr virus infection in 53 pediatric cases.
Lu G, Xie ZD, Zhao SY, Ye LJ, Wu RH, Liu CY, Yang S, Jin YK, Shen KL. Lu G, et al. Chin Med J (Engl). 2009 Feb 5;122(3):262-6. Chin Med J (Engl). 2009. PMID: 19236801
BACKGROUND: Chronic active Epstein-Barr virus infection (CAEBV) has been previously reported to be sometimes associated with an aggressive clinical course. ...Many patients with CAEBV generally had continuous symptoms during the observ
BACKGROUND: Chronic active Epstein-Barr virus infection (CAEBV) has been previously reported to be …
Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.
Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T. Kimura H, et al. Blood. 2001 Jul 15;98(2):280-6. doi: 10.1182/blood.v98.2.280. Blood. 2001. PMID: 11435294 Free article.
Patients were divided into 2 clinically distinct groups, based on whether the predominantly infected cells in their peripheral blood were T cells or natural killer (NK) cells. Over a 68-month period of observation, 10 patients died from hepatic failure, malignant lymphoma, …
Patients were divided into 2 clinically distinct groups, based on whether the predominantly infected cells in their peripheral blood were T …
Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation.
Gotoh K, Ito Y, Shibata-Watanabe Y, Kawada J, Takahashi Y, Yagasaki H, Kojima S, Nishiyama Y, Kimura H. Gotoh K, et al. Clin Infect Dis. 2008 May 15;46(10):1525-34. doi: 10.1086/587671. Clin Infect Dis. 2008. PMID: 18419486
CONCLUSIONS: The number of life-threatening complications and plasma viral load are indicative of the stage of disease progression and may be useful factors for predicting the outcome of HSCT....
CONCLUSIONS: The number of life-threatening complications and plasma viral load are indicative of the stage of disease progression and may b …
38 results